Genomic Vision (GV.PA) Stock Analyst Ratings

EPA:GV • FR0011799907

0.0018 EUR
+0 (+5.88%)
Last: Nov 3, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

35

ChartMill assigns a Buy % Consensus number of 35% to GV.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • GV.PA was analyzed by 8 analysts. The buy percentage consensus is at 35. So analysts seem to be rather negative about GV.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • GV.PA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
GV.PA Historical Analyst RatingsGV.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6
GV.PA Current Analyst RatingGV.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades

Genomic Vision / GV.PA FAQ

What is the consensus rating for Genomic Vision (GV.PA) stock?

The consensus rating for Genomic Vision (GV.PA) is 35 / 100 . This indicates that analysts generally have a negative outlook on the stock.


How many analysts cover Genomic Vision (GV.PA) stock?

The number of analysts covering Genomic Vision (GV.PA) is 8.